Novo Nordisk Total Liabilities and Share Holders Equity 2010-2025 | NVO

Novo Nordisk total liabilities and share holders equity for the quarter ending March 31, 2025 was $69.021B, a 58.58% increase year-over-year.

  • Novo Nordisk total liabilities and share holders equity for 2024 was $67.54B, a 47.91% increase from 2023.
  • Novo Nordisk total liabilities and share holders equity for 2023 was $45.663B, a 33.67% increase from 2022.
  • Novo Nordisk total liabilities and share holders equity for 2022 was $34.162B, a 10.39% increase from 2021.

Novo Nordisk Total Liabilities and Share Holders Equity 2010-2025 | NVO

  • Novo Nordisk total liabilities and share holders equity for 2024 was $67.54B, a 47.91% increase from 2023.
  • Novo Nordisk total liabilities and share holders equity for 2023 was $45.663B, a 33.67% increase from 2022.
  • Novo Nordisk total liabilities and share holders equity for 2022 was $34.162B, a 10.39% increase from 2021.